Het Health Valley Event 2026 (HVE) op 12 maart in De Vasim Nijmegen is dé plek om de toekomst van gezondheid en innovatie te ontdekken en is de bruisende ontmoetingsplek voor professionals in de zorg. Laat je gedurende de dag inspireren door verschillende keynote sprekers en de nieuwste innovaties op de beursvloer om met elkaar invulling te geven aan de transitie richting toekomstbestendige zorg.
Het HVE biedt je alles wat je nodig hebt om de toekomst van de zorg te verkennen: sessies boordevol inzichten, interactieve workshops en een beursvloer met de nieuwste innovaties. Ontdek hoe technologie de zorg verandert, raak geïnspireerd door praktische voorbeelden en benut de unieke netwerkkansen om samen te werken aan een toekomstbestendige zorgsector. Een programma vol waardevolle ontmoetingen en vooruitstrevende ideeën die je niet wil missen!
Meld je nu aan en gebruik de kortingscode van Briskr: 26BRSR50 bij het bestellen van je kaartje. Dan ontvang je 50% korting.
Op 5 maart organiseren wij een inspirerende middag voor partners, nieuwe partners en innovators om de nieuwe ronde van het Digital Health Challenge Lab (DHCL) te verkennen. Ontdek lopende projecten, leer nieuwe innovators kennen en maak waardevolle verbindingen.
Het Digital Health Challenge Lab (DHCL) is een open innovatieprogramma waarin zorg- en welzijnsorganisaties, ziekenhuizen, woningcorporaties, startups, kennisinstellingen en bedrijven samenwerken aan echte uitdagingen uit de praktijk.
In co-creatie ontwikkelen we digitale oplossingen die werken; getest, toegepast en klaar voor opschaling.
The Business Angels Network Nijmegen (BANN) is an initiative from Briskr and OostNL to connect angel investors with promising startups in health and hightech in the metropole region Arnhem-Nijmegen. In three events per year 12 startups in total are giving the opportunity to pitch their business idea and investment opportunity to an audience of interested investors. The normal range of investment is between 50K to 300K but in some cases a combination can be made with other investment channels. The event is invite only.
The meetings are held a Slot Doddendael in Ewijk (next to Nijmegen), start around 16:00 and are combined with dinner until 20:00.
For investors
The BANN is a network of 100+ investors interested in health and hightech sectors. Of these usually around 40 investors are present during the meetings. Before the meeting you will receive information about the startups to determine if a visit is justified. Beside the investment opportunities the BANN is also a social gathering including plenty of opportunity to network with other angels during dinner.
Read more in this infographic. and look back to the BANN-event on June 4th here.
The BANN is supported by the partners of Briskr: BDO, Briskr, EP&C, Gemeente Nijmegen, JLABS, Oost NL, Qserve, Rabobank Rijk van Nijmegen and The Economic Board.
Join us for an insightful, day-long event dedicated to PhD candidates and postdoctoral researchers. Discover diverse career opportunities both within and beyond academia through a series of inspiring keynote speeches from professionals who have navigated various career paths.
Participate in practical workshops focused on enhancing your communication, networking, entrepreneurship, and consultancy skills. Network at our company market with representatives from various industries and academic institutions. Empower your future and take the first step towards realizing your potential.
Read more how to join or participate as entrepreneur at this event.
On October 8, the fifth edition of the Radboudumc Investment Day took place at the Experience Center. Scientists, entrepreneurs, and investors from the life sciences & health sector gathered to exchange knowledge, network, and explore new collaborations.
The event was jointly organized by Briskr, Oost NL, Radboudumc, and Radboud University. With over 241 attendees, the turnout once again surpassed the previous year.
Mayor Bruls and Invest-NL
The day was opened by Mayor Bruls of Nijmegen, who attended the event in honor of its lustrum. The mayor emphasized the importance of forging new connections to successfully bring innovations to market and urged all attendees to actively pursue this goal. He also highlighted Nijmegen’s strengths as a breeding ground for innovation—a city with a rich history and a young, highly educated, and creative population.
The keynote speaker was Rinke Zonneveld, CEO of Invest-NL. In a conversation with Wieteke Numan from Oost NL, he discussed current developments in Dutch health companies. Zonneveld pointed out a growing challenge for early-stage companies: securing enough funding to make the leap from start-up to scale-up. He called on the attending investors to join Invest-NL in putting more energy—and courage—into taking risks.
As in previous years, the day’s program focused on fostering new connections. In addition to informative sessions, there was ample opportunity for one-on-one meetings, which could be scheduled in advance or during the event via a matching tool. Others met spontaneously during breaks, networking drinks, and the dinner afterward.
Radboudumc Team Wins Venture Challenge Drug Repurposing
This year, Investment Day hosted the final round of the Venture Challenge, a national initiative that helps early-stage entrepreneurs refine their ideas. This edition focused on drug repurposing: applying existing medications to new uses.
The Radboudumc team SAVE emerged as the winner. SAVE aims to repurpose the drug Sirolimus for rare congenital vascular anomalies, where it has shown high effectiveness. The team consists of Maroeska te Loo, Veroniek Harbers, Edith Klappe, and Carine van der Vleuten. They received a €20,000 incentive prize to further develop their initiative.
Angela Soares Wins Martijn Kriens Best Poster Award
PhD candidate Angela Soares won the event’s poster competition (see photo). Her research explores the use of integrated sensing cell-signatures (ISS) to detect infected joint prostheses. This method has the potential to identify infections much faster and more patient-friendly than current diagnostic techniques.
Angela received the Martijn Kriens Best Poster Award: a €2,500 encouragement prize for her idea. Entries were judged not only on scientific merit but also on their potential to evolve into successful products.
Organized by Radboudumc, Briskr, Oost NL, and Radboud University: the main match-making event for top researchers, entrepreneurs and investors in the life sciences & health sector. Exchange knowledge, network, and speak to investors about (future) cooperation early on. Our goal: to improve the impact on healthcare.
The main objective of this day is to make new contacts. For that we are using a matchmaking platform to set up 1-on-1 meetings.
A balanced selection of scientists, investors, and entrepreneurs shares their stories so that all attendees could learn from each other. The program for edition 2025 is to be announced.
What a vibrant afternoon it was! Yesterday’s SMB Network Meeting truly lived up to its theme: Innovate & Connect. From the very first moment, the energy was high — people started networking as soon as they walked in, and they didn’t stop.
With no chairs and no stage, the setup encouraged continuous conversation. This standing-only format was a first — and it turned out to be a huge success: a full-on networking event from start to finish.
One of the highlights? The diversity of the participating companies — from ambitious startups to growing scale-ups and established corporates, active in both health and hightech. All of them entrepreneurs, actively building something, just real innovations and passionate founders. That mix created an inviting open & authentic atmosphere.
A big thank you to the companies who shared their work through short pitches and at the buzzing company market:
New connections were made, ideas exchanged, and future plans sparked — all in the spirit of collaboration and innovation in the Health & Hightech ecosystem. Thanks to everyone who took part in this session — as alone you go fast, but together, we go further!
Date: August 28, 2025 Registration and company market: 15:30 Program: 16:00-17:00 hrs (+ networking, drinks & small buffet) Location: Noviotech Campus Nijmegen, building M, Meet&Greet area
It’s time to reconnect! Join us for a fresh edition of the SMB Network Meeting — a late afternoon dedicated to connecting, sharing, and discovering what’s next in health and hightech. Step into the future and be part of the change in Nijmegen — the city of health and hightech!
Our region is buzzing with innovative startups and scale-ups shaping tomorrow’s solutions. We invite you to exchange ideas and discover new opportunities.
Floor van de Watering will kick off the meeting by sharing how Briskr supports entrepreneurs in our thriving ecosystem, followed by short pitches by the entrepreneurs with table top stands. But most importantly, as the summer holiday season comes to an end we’ll focus on (re)connecting, sharing and growing together whilst enjoying drinks and good food!
Let’s help each other move further — faster.
Live event
This event will be organized in a live setting at Noviotech Campus in Nijmegen (building M, Meet&Greet area).
Good to know
Presentations are in English & the entrance is free (registration upfront is needed though). We welcome new guests, so please feel free to pass on this invitation to relevant people in your network!
Be one of the first to register for this SMB Network Meeting:
In a few minutes you will receive an email confirmation from events@smb-lifesciences.nl (you may need to check your spam messages). And a few days before the event we will send you an email from marion.schouten@briskr.nl with an updated program and practical information (directions and parking). Feel free to contact us at marion.schouten@briskr.nl should you have any questions in the meantime! We look forward to meeting you!
Eén sterk merk voor innovatie en samenwerking in de regio Arnhem-Nijmegen
Op woensdag 4 juni is het officiële startsein gegeven voor Lifeport Regio Arnhem Nijmegen – het merk voor de regio waar innovatie, talent en samenwerking centraal staan. Onder deze naam bundelen ondernemers, overheden en onderwijs- en kennisinstellingen hun krachten om samen te werken aan baanbrekende oplossingen voor de grote uitdagingen van vandaag én morgen.
Lifeport Regio Arnhem Nijmegen: één gezicht, één krachtig verhaal
Lifeport is de naam waaronder 800.000 inwoners, 50.000 bedrijven, 17 gemeenten en meer dan 60.000 studenten samenwerken aan de toekomst. Lifeport Regio Arnhem Nijmegen maakt zichtbaar wat de regio al jaren kenmerkt: toonaangevende innovatie op het gebied van Energy, Health en High Tech. De energietransitie, vergrijzing, klimaatvraagstukken en de druk op de zorg zijn nog maar enkele van de vraagstukken die we vandaag tegenkomen. Te groot om individueel en los van elkaar (overheid, onderneming, onderzoeksinstituut, onderwijsinstelling) op te lossen. Samen zijn we krachtiger. Alleen samen lopen we voorop.
On June 3, the Molecule 2 Business event brought together a vibrant mix of participants from the worlds of science, business, government, and education at Noviotech Campus in Gemeente Nijmegen. The central theme? Next-Level Collaboration – and how it fuels the future of drug discovery.
Keynote speaker Carmen van Vilsteren. Health~Holland plays as an architect and integrator. She highlighted how initiatives like Women’s Health and Organ-on-a-Chip are part of a broader, interconnected innovation landscape. Next-level collaboration is multi-layered. From strategic alliances to living labs, and from local to international partnerships – all types of collaboration are needed:
– Cross-functional teams
– Public-private (quadruple helix) partnerships
– Living labs and consortia
– Strategic alliances
– Regional, national, and international networks
Highlights from the breakout sessions and round table discussions included:
Pharma Delta emphasized the need for a strong public-private consortium with short communication lines, robust infrastructure, and a clear focus on human capital.
Municipalities of Gemeente Oss and Gemeente Nijmegen expressed a shared ambition: to create an online platform that connects the dots between regional initiatives and offers a clear roadmap for collaboration.
HAN University of Applied Sciences underlined the importance of preparing students for the full drug development lifecycle, from lab to patient.
Researchers discussed the need for broader awareness of the end-to-end process — including the final impact on patients.
The topic of drug repurposing and valorisation sparked lively discussion. The key takeaway? Always start with a viable business case — one that’s both accessible and sustainable. And don’t hesitate to seek advice early in the process.
And there was also a strong call to bring patients and investors more explicitly into the conversation in future sessions.
In summary:
Collaboration should serve a clear, shared goal. With intrinsic motivation, trust and a willingness to share knowledge as essential ingredients for success.
As one participant noted:
“Embrace the chaos – it’s where true innovation begins.”
SMB Life Sciences maakt gebruikt van cookies. Onze website laat ‘cookies’ (tekstbestandjes die op uw computer, tablet of telefoon worden geplaatst) achter om de website goed te laten functioneren. Door deze cookies verbeteren wij onze dienstverlening. Goed om te weten is dat cookies niet opslaan wie u bent. Uw naam, adres, leeftijd en andere persoonlijke gegevens zijn niet bekend bij ons door het gebruik van cookies.
We maken gebruik van functionele cookies op onze website. Deze cookies zijn nodig voor het functioneren van de website. Zonder deze cookies kan de site niet volledig weergegeven worden.
We maken geen gebruik van social media deelknoppen op de site. En we hebben daarvoor ook geen cookies geplaatst.
We maken wel gebruik van Google Analytics. Via Google Analytics verzamelen we gegevens over het bezoekgedrag van de website. Het is voor ons zichtbaar hoe de bezoeker zich door de website navigeert. Deze informatie kunnen we gebruiken om de website te verbeteren. Deze informatie niet worden herleidt naar een individu.
Het privacy statement van SMB Life Sciences geeft aan welke persoonsgegevens verwerkt worden en op welke manier. Persoonsgegevens zijn gegevens waarmee een natuurlijk persoon geïdentificeerd kan worden of identificeerbaar is. Wij respecteren uw privacy en dragen er zorg voor dat uw gegevens altijd in overeenstemming met de Algemene Verordening Gegevensbescherming worden behandeld.
SMB Life Sciences is partner binnen het consortium Briskr Health & High Tech Generator.
Wij gebruiken uw persoonsgegevens om u op de hoogte te houden van actualiteiten rondom SMB en/of Briskr en uitnodigingen voor (passende) evenementen aan u te verzenden. Uw contactgegevens worden bewaard in het kader van toestemming.
Deze manier van bewaren van uw persoonsgegevens is in overeenstemming met de Algemene Verordening Gegevensbescherming (hierna te noemen ‘AVG’).
